5.40

9.09% 0.45

Gridai Technologies Corp (GRDX)

Overview News Price History Discussions Forecast

Gridai Technologies Corp stock is traded at $5.40, with a volume of 181.39K. It is up +9.09% in the last 24 hours and up +42.86% over the past month. GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Previous Close:

$4.95

Open:

$5.2

24h Volume:

181.39K

Relative Volume:

1.54

Market Cap:

$35.98M

Revenue:

$74,500

Net Income/Loss:

$-8.73M

P/E Ratio:

-1.8154

EPS:

-2.9745

Net Cash Flow:

$-6.67M

1W Performance:

-8.47%

1M Performance:

+42.86%

6M Performance:

+169.33%

1Y Performance:

+0.00%

1-Day Range:

$4.96

$5.47

1-Week Range:

$4.51

$5.967

52-Week Range:

$1.87

$6.9291

Gridai Technologies Corp Stock (GRDX) Company Profile

Name

Gridai Technologies Corp

Sector

Healthcare (1104)

Industry

Biotechnology (617)

Phone

561-589-7020

Address

433 PLAZA REAL, BOCA RATON

Employee

Twitter

Next Earnings Date

2026-05-28

Latest SEC Filings

GRDX's Discussions on Twitter

Compare GRDX vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GRDX Gridai Technologies Corp	5.40	35.98M	74,500	-8.73M	-6.67M	-2.9745
VRTX Vertex Pharmaceuticals Inc	451.63	114.63B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	609.94	63.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.72	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	278.09	37.13B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	162.99	34.65B	742.00K	-1.37B	-1.07B	-7.0731

Gridai Technologies Corp Stock (GRDX) Latest News

Jun 18, 2026

GridAI Technologies Ord Shs (GRDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 18, 2026

GridAI Technologies Ord Shs - TradingKey

Jun 18, 2026

GridAI Technologies Ord Shs (GRDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026

GridAI Technologies Ord Shs (GRDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 18, 2026

Jun 17, 2026

GridAI Technologies Ord Shs (GRDX) Institutional Confidence - TradingKey

Jun 17, 2026

GridAI Technologies Ord Shs (GRDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

GridAI Technologies Ord Shs (GRDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

GridAI Technologies Ord Shs (GRDX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 15, 2026

GridAI Technologies Ord Shs (GRDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 15, 2026

Jun 14, 2026

Q1 2026 Earnings: GRDX Posts EPS of -$0.82; Stock Declines $10.68 as Revenue UnreportedFinancial Health Score - newsline.com

Jun 14, 2026

Jun 08, 2026

GridAI Technologies (GRDX) Edges Lower as Key Support Levels Remain in FocusStock News - newsline.com

Jun 08, 2026

Jun 07, 2026

Number of shareholders of GridAI Technologies Corp. – NASDAQ:GRDX - TradingView

Jun 07, 2026

Jun 04, 2026

1.31M shares tied to warrants registered for resale by GridAI (NASDAQ: GRDX) - Stock Titan

Jun 04, 2026

Jun 03, 2026